SynCore Biotechnology Co Financial Leverage

Financial Leverage (Equity Multiplier) of SynCore Biotechnology Co is 1.04 in 2026.

Financial Leverage (Equity Multiplier) of SynCore Biotechnology Co changed from 1.08 to 1.04, representing a -3.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) SynCore Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s SynCore Biotechnology Co with sector peers and the industry average to assess whether it is attractive.